AR032284A1 - Transferencia nuclear con celulas donantes seleccionadas - Google Patents
Transferencia nuclear con celulas donantes seleccionadasInfo
- Publication number
- AR032284A1 AR032284A1 ARP000104816A ARP000104816A AR032284A1 AR 032284 A1 AR032284 A1 AR 032284A1 AR P000104816 A ARP000104816 A AR P000104816A AR P000104816 A ARP000104816 A AR P000104816A AR 032284 A1 AR032284 A1 AR 032284A1
- Authority
- AR
- Argentina
- Prior art keywords
- cells
- reconstituted
- cell
- nutraceutical
- pharmaceutical
- Prior art date
Links
- 238000000034 method Methods 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 3
- 210000004027 cell Anatomy 0.000 abstract 3
- 210000002308 embryonic cell Anatomy 0.000 abstract 2
- 239000002417 nutraceutical Substances 0.000 abstract 2
- 235000021436 nutraceutical agent Nutrition 0.000 abstract 2
- 230000002062 proliferating effect Effects 0.000 abstract 2
- 230000009261 transgenic effect Effects 0.000 abstract 2
- 230000022131 cell cycle Effects 0.000 abstract 1
- 238000010367 cloning Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 210000002257 embryonic structure Anatomy 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 210000001161 mammalian embryo Anatomy 0.000 abstract 1
- 210000003370 receptor cell Anatomy 0.000 abstract 1
- 238000005204 segregation Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002689 xenotransplantation Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1323—Adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/99—Coculture with; Conditioned medium produced by genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Hematology (AREA)
- Plant Pathology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Oncology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ337792A NZ337792A (en) | 1999-09-14 | 1999-09-14 | Nuclear transfer and use in cloning |
Publications (1)
Publication Number | Publication Date |
---|---|
AR032284A1 true AR032284A1 (es) | 2003-11-05 |
Family
ID=19927507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000104816A AR032284A1 (es) | 1999-09-14 | 2000-09-14 | Transferencia nuclear con celulas donantes seleccionadas |
Country Status (8)
Country | Link |
---|---|
JP (1) | JP2004500038A (fr) |
CN (1) | CN1424870A (fr) |
AR (1) | AR032284A1 (fr) |
AU (1) | AU784371B2 (fr) |
DE (1) | DE10084987T1 (fr) |
GB (1) | GB2369828B (fr) |
NZ (1) | NZ337792A (fr) |
WO (1) | WO2001019182A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7122177B2 (en) | 2000-01-20 | 2006-10-17 | Diabcell Pty Ltd. | Preparation and xenotransplantation of porcine islets |
JP2006508676A (ja) * | 2002-12-10 | 2006-03-16 | ジーティーシー バイオセラピューティックス インコーポレイテッド | 追加の核移植のための細胞ドナーとして体細胞核移植胚を利用する方法および系 |
JP2006081542A (ja) * | 2004-08-18 | 2006-03-30 | Institute Of Physical & Chemical Research | クローン哺乳動物の作成方法 |
JP2010075099A (ja) * | 2008-09-26 | 2010-04-08 | Japan Science & Technology Agency | 哺乳動物核移植胚のスクリーニング方法、非ヒト哺乳動物核移植胚、クローン非ヒト哺乳動物、及びスクリーニングキット |
EP3188763B1 (fr) * | 2014-09-02 | 2020-05-13 | The Regents of The University of California | Procédés et compositions pour assurer la modification de l'adn cible arn dépendante |
CN105483216B (zh) * | 2015-11-30 | 2019-01-15 | 四川农业大学 | 一种家兔cetp基因检测肉质育种的方法 |
CN108624621B (zh) * | 2018-01-17 | 2019-04-12 | 中国科学院上海生命科学研究院 | 非人灵长类的体细胞克隆动物的制备方法 |
JP2023516484A (ja) | 2020-03-11 | 2023-04-19 | ビット バイオ リミテッド | 肝細胞作製方法 |
CN111793671A (zh) * | 2020-07-22 | 2020-10-20 | 中国农业大学 | 一种优化的适用于绵羊染色体二元流式分选的染色体悬液制备方法 |
CN112715479A (zh) * | 2021-01-06 | 2021-04-30 | 吉沙阿牛 | 一种山羊生态循环养殖方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1067834A4 (fr) * | 1998-03-16 | 2002-01-23 | Garelag Pty Ltd | Transfert de noyau de cellules porcines |
-
1999
- 1999-09-14 NZ NZ337792A patent/NZ337792A/en not_active IP Right Cessation
-
2000
- 2000-09-14 GB GB0205915A patent/GB2369828B/en not_active Expired - Fee Related
- 2000-09-14 CN CN00813845A patent/CN1424870A/zh active Pending
- 2000-09-14 AR ARP000104816A patent/AR032284A1/es unknown
- 2000-09-14 JP JP2001522836A patent/JP2004500038A/ja active Pending
- 2000-09-14 WO PCT/NZ2000/000179 patent/WO2001019182A1/fr active Application Filing
- 2000-09-14 DE DE10084987T patent/DE10084987T1/de not_active Withdrawn
- 2000-09-14 AU AU74624/00A patent/AU784371B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JP2004500038A (ja) | 2004-01-08 |
NZ337792A (en) | 2002-03-28 |
WO2001019182A1 (fr) | 2001-03-22 |
GB2369828A (en) | 2002-06-12 |
DE10084987T1 (de) | 2003-04-17 |
CN1424870A (zh) | 2003-06-18 |
AU7462400A (en) | 2001-04-17 |
AU784371B2 (en) | 2006-03-23 |
GB0205915D0 (en) | 2002-04-24 |
GB2369828B (en) | 2004-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Eggan et al. | Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation | |
Wang et al. | Generation of completely embryonic stem cell-derived mutant mice using tetraploid blastocyst injection | |
George et al. | Familial dysautonomia model reveals Ikbkap deletion causes apoptosis of Pax3+ progenitors and peripheral neurons | |
Meredith et al. | Overactive bladder and incontinence in the absence of the BK large conductance Ca2+-activated K+ channel | |
Alenina et al. | Growth retardation and altered autonomic control in mice lacking brain serotonin | |
Shemer et al. | Structure of the imprinted mouse Snrpn gene and establishment of its parental-specific methylation pattern | |
Sun et al. | Specificity and efficiency of reporter expression in adult neural progenitors vary substantially among nestin‐CreERT2 lines | |
Liu et al. | Generation of a monkey with MECP2 mutations by TALEN-based gene targeting | |
Tyynismaa et al. | Mouse models of mitochondrial DNA defects and their relevance for human disease | |
Barber et al. | Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion | |
Masubuchi et al. | Protein phosphatase PHLPP1 controls the light-induced resetting of the circadian clock | |
Maurya et al. | Positive and negative regulation of Gli activity by Kif7 in the zebrafish embryo | |
Ma et al. | The effects of DNA double-strand breaks on mouse oocyte meiotic maturation | |
Zeng et al. | EHMT2 and SETDB1 protect the maternal pronucleus from 5mC oxidation | |
AR032284A1 (es) | Transferencia nuclear con celulas donantes seleccionadas | |
Zhang et al. | Expression patterns and potential biological roles of Dip2a | |
Hook et al. | Functional identity of the gamma tropomyosin gene: Implications for embryonic development, reproduction and cell viability | |
Karadurmus et al. | GPRIN3 controls neuronal excitability, morphology, and striatal-dependent behaviors in the indirect pathway of the striatum | |
Katoh et al. | Fluorescent visualisation of the hypothalamic oxytocin neurones activated by cholecystokinin‐8 in rats expressing c‐fos‐enhanced green fluorescent protein and oxytocin‐monomeric red fluorescent protein 1 fusion transgenes | |
Choi et al. | Simultaneous deletion of floxed genes mediated by CaMKIIα-Cre in the brain and in male germ cells: application to conditional and conventional disruption of Goα | |
Dann | New technology for an old favorite: lentiviral transgenesis and RNAi in rats | |
Coppola et al. | Epibranchial ganglia orchestrate the development of the cranial neurogenic crest | |
Andrae et al. | Characterization of platelet-derived growth factor-A expression in mouse tissues using a lacZ knock-in approach | |
Kong et al. | Generation of Elf5‐Cre knockin mouse strain for trophoblast‐specific gene manipulation | |
McGee et al. | Golga5 is dispensable for mouse embryonic development and postnatal survival |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |